Navigation Links
Asymchem Announces sFDA Certification for Drug Product Manufacturing
Date:6/4/2009

TEDA TIANJIN, China, June 4 /PRNewswire/ -- Asymchem Laboratories, Inc., a leading research-based contract manufacturer of intermediates, API's and drug products to the pharmaceutical industry, is pleased to announce the issuance by the Tianjin branch of the Chinese State Food and Drug Administration (sFDA), a manufacturing certificate for drug products to our Tianjin 2 site. This qualifies Asymchem to manufacture oral solid dosage forms including tablets, capsules, and pellets.

Asymchem offers preclinical and drug product programs that include preformulation and formulation development, and clinical supply manufacturing of oral dosage forms. Housed in a 250 m2 state-of-the-art facility in Asymchem's Tianjin 2 site, Asymchem's drug product manufacturing facility is capable of producing up to kilogram scale of tablets or capsules per batch to support phase 1 and phase 2 clinical studies. Separate facility of similar scale exists for manufacture of dosage forms containing highly potent or cytotoxic compounds. Meanwhile, a much larger drug product facility for commercial manufacturing is being built and expected to be operational by 2Q 2010.

"We feel drug product capabilities to support all phases of our collaborator's research, development, and manufacturing are a logical extension of our long-standing capabilities in API development and manufacturing," states Dr. Hao Hong, CEO of Asymchem. "Our recent successful sFDA audit demonstrates that we bring the same focus on quality and regulatory compliance to our drug product programs that we have always brought to our API programs."

Dr. Xiaorong He, director of Formulation Development for Asymchem adds: "Operating to the highest technical and regulatory standards is part of the Asymchem culture, and our recent certification demonstrates our commitment to these ideals."

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14 year track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Asymchem Continues to Maintain a Good Running Posture, Despite Economic Crisis
2. Asymchem Announces Opening of High Potency API and Drug Product Facility
3. LOHAS Announces Final Program Line-up Including Speakers from Wal-Mart, Coca Cola, MINI, Facebook Causes, Saatchi & SaatchiS, Gaiam and eBay
4. Healthcare Data Services (HDS) Announces HDS Expert(SM)
5. Aesthera Announces Installation of 1000th Photopneumatic System in US
6. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
7. Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference
8. Anpath Group, Inc. Announces Selection of its Cleaner by the Toronto Transit System
9. Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
10. US Oncology, Inc. Announces $465 Million Senior Secured Notes Offering
11. DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: